Rutgers geneticist Linda Brzustowicz and her colleagues have identified a specific DNA change that is likely to increase risk for developing schizophrenia in some people. It provides a potential mechanism that may be a point of entry for drug therapy, consistent with the growing trend of personalized medicine.
The research findings are reported in the April issue of the American Journal of Psychiatry (AJP). An accompanying editorial highlights the significance of this work.
Brzustowicz, a professor of genetics at Rutgers, The State University of New Jersey, and board-certified psychiatrist, said that the research has demonstrated a functional DNA change that increases gene expression. This conclusion is based on its presence in the genes of a Canadian study population of 24 families where multiple individuals had been diagnosed with schizophrenia. The gene in question, NOS1AP, previously known as CAPON, is one which Brzustowicz has been studying for six years.
a researcher where I worked is looking at some of the identified genes in differences to medication response. Interesting stuff coming down the pipeline
Clipped to Mental Health and Wellness
Thank you for the clip 4real?
a researcher where I worked is looking at some of the identified genes in differences to medication response. Interesting stuff coming down the pipeline
Any interesting development you might know of?
Yeah she has shown that certain geneotypes respond better to atypical antipsychotics while other respond to typicals. She also correlated the difference in geneotypes to differences in f MRI (her specialty). Her sample size is small and she is still crunching data. When she publishes I will post her paper. You can google Adreinne Lahti and see some of her other work
Thank you for the information. If possible please notify me when you post the paper.
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |